ArticleBioconjugate chemistry2026

A Tetrameric Biotin-Avidin Scaffold Using Anti-CD19 (FMC63) Traptavidin Fusion Enables High-Avidity CAR-T Cells for Leukemia Therapy.

Hae Li Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.